The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease

Approximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablati...

Full description

Bibliographic Details
Main Authors: Dimitrios K. Filippiadis, Georgios Velonakis, Alexis Kelekis, Constantinos T. Sofocleous
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/2/308
id doaj-ea61b48f6c98432383dcf1d2798af57a
record_format Article
spelling doaj-ea61b48f6c98432383dcf1d2798af57a2021-02-15T00:03:37ZengMDPI AGDiagnostics2075-44182021-02-011130830810.3390/diagnostics11020308The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic DiseaseDimitrios K. Filippiadis0Georgios Velonakis1Alexis Kelekis2Constantinos T. Sofocleous32nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, Athens 12462, Greece2nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, Athens 12462, Greece2nd Department of Radiology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, Athens 12462, GreeceMemorial Sloan Kettering Cancer Center, Weill-Cornell Medical College, New York, NY 10065, USAApproximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablation (TA) is recommended in the treatment of limited liver metastases as free-standing therapy or in combination with surgery as long as all visible disease can be eradicated. Percutaneous TA has been proven as a safe and efficacious therapy offering sustained local tumor control and improved patient survival. Continuous technological advances in diagnostic imaging and guidance tools, the evolution of devices allowing for optimization of ablation parameters, as well as the ability to perform margin assessment have improved the efficacy of ablation. This allows resectable small volume diseases to be cured with percutaneous ablation. The ongoing detailed information and increasing understanding of tumor biology, genetics, and tissue biomarkers that impact oncologic outcomes as well as their implications on the results of ablation have further allowed for treatment customization and improved oncologic outcomes even in those with more aggressive tumor biology. The purpose of this review is to present the most common indications for image-guided percutaneous ablation in colorectal cancer liver metastases, to describe technical considerations, and to discuss relevant peer-reviewed evidence on this topic. The growing role of imaging and image-guidance as well as controversies regarding several devices are addressed.https://www.mdpi.com/2075-4418/11/2/308ablation techniquesliver ablationcolorectal cancerhepatic metastasisinterventional oncologythermal ablation
collection DOAJ
language English
format Article
sources DOAJ
author Dimitrios K. Filippiadis
Georgios Velonakis
Alexis Kelekis
Constantinos T. Sofocleous
spellingShingle Dimitrios K. Filippiadis
Georgios Velonakis
Alexis Kelekis
Constantinos T. Sofocleous
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
Diagnostics
ablation techniques
liver ablation
colorectal cancer
hepatic metastasis
interventional oncology
thermal ablation
author_facet Dimitrios K. Filippiadis
Georgios Velonakis
Alexis Kelekis
Constantinos T. Sofocleous
author_sort Dimitrios K. Filippiadis
title The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
title_short The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
title_full The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
title_fullStr The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
title_full_unstemmed The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
title_sort role of percutaneous ablation in the management of colorectal cancer liver metastatic disease
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2021-02-01
description Approximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablation (TA) is recommended in the treatment of limited liver metastases as free-standing therapy or in combination with surgery as long as all visible disease can be eradicated. Percutaneous TA has been proven as a safe and efficacious therapy offering sustained local tumor control and improved patient survival. Continuous technological advances in diagnostic imaging and guidance tools, the evolution of devices allowing for optimization of ablation parameters, as well as the ability to perform margin assessment have improved the efficacy of ablation. This allows resectable small volume diseases to be cured with percutaneous ablation. The ongoing detailed information and increasing understanding of tumor biology, genetics, and tissue biomarkers that impact oncologic outcomes as well as their implications on the results of ablation have further allowed for treatment customization and improved oncologic outcomes even in those with more aggressive tumor biology. The purpose of this review is to present the most common indications for image-guided percutaneous ablation in colorectal cancer liver metastases, to describe technical considerations, and to discuss relevant peer-reviewed evidence on this topic. The growing role of imaging and image-guidance as well as controversies regarding several devices are addressed.
topic ablation techniques
liver ablation
colorectal cancer
hepatic metastasis
interventional oncology
thermal ablation
url https://www.mdpi.com/2075-4418/11/2/308
work_keys_str_mv AT dimitrioskfilippiadis theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT georgiosvelonakis theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT alexiskelekis theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT constantinostsofocleous theroleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT dimitrioskfilippiadis roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT georgiosvelonakis roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT alexiskelekis roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
AT constantinostsofocleous roleofpercutaneousablationinthemanagementofcolorectalcancerlivermetastaticdisease
_version_ 1724269347732455424